IgE-Mediated Immune Response and Antibody-Mediated Rejection

Clin J Am Soc Nephrol. 2020 Oct 7;15(10):1474-1483. doi: 10.2215/CJN.02870320. Epub 2020 Sep 9.

Abstract

Background and objectives: Active antibody-mediated rejection is the main cause of kidney transplant loss, sharing with SLE the alloimmune response and the systemic activation of the IFN-α pathway. IgE-mediated immune response plays a key role in the development of SLE nephritis and is associated with IFN-α secretion. The aim of our study was to investigate IgE-mediated immune response in antibody-mediated rejection.

Design, setting, participants, & measurements: This was a cross-sectional study of 56 biopsy-proven antibody-mediated rejection study participants, 80 recipients with normal graft function/histology (control), 16 study participants with interstitial fibrosis/tubular atrophy, and six participants with SLE. We evaluated graft IgE deposition, tryptase (a mast cell marker), and CD203 (a specific marker of activated basophils) by immunofluorescence/confocal microscopy. In addition, we measured serum concentration of human myxovirus resistance protein 1, an IFN-α-induced protein, and anti-HLA IgE.

Results: We observed a significantly higher IgE deposition in tubules and glomeruli in antibody-mediated rejection (1766±79 pixels) and SLE (1495±43 pixels) compared with interstitial fibrosis/tubular atrophy (582±122 pixels) and control (253±50 pixels). Patients with antibody-mediated rejection, but not control patients and patients with interstitial fibrosis/tubular atrophy, presented circulating anti-HLA IgE antibodies, although with a low mean fluorescence intensity. In addition, immunofluorescence revealed the presence of both mast cells and activated basophils in antibody-mediated rejection but not in control and interstitial fibrosis/tubular atrophy. The concentration of circulating basophils was significantly higher in antibody-mediated rejection compared with control and interstitial fibrosis/tubular atrophy. MxA serum levels were significantly higher in antibody-mediated rejection compared with control and correlated with the extent of IgE deposition.

Conclusions: Our data suggest that IgE deposition and the subsequent recruitment of basophils and mast cells within the kidney transplant might play a role in antibody-mediated rejection.

Keywords: IgE; basophils; chronic rejection; interferon alpha; mast cells.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Allografts / metabolism
  • Allografts / pathology
  • Atrophy / metabolism
  • Atrophy / pathology
  • Basophils / pathology
  • Cross-Sectional Studies
  • Female
  • Fibrosis
  • Graft Rejection / blood
  • Graft Rejection / immunology*
  • Graft Rejection / metabolism*
  • Graft Rejection / pathology
  • HLA Antigens / immunology
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / metabolism*
  • Kidney / metabolism*
  • Kidney / pathology*
  • Kidney Glomerulus / metabolism
  • Kidney Glomerulus / pathology
  • Kidney Transplantation / adverse effects
  • Kidney Tubules / metabolism
  • Kidney Tubules / pathology
  • Lupus Nephritis / metabolism
  • Male
  • Mast Cells / pathology
  • Middle Aged
  • Myxovirus Resistance Proteins / blood

Substances

  • HLA Antigens
  • MX1 protein, human
  • Myxovirus Resistance Proteins
  • Immunoglobulin E